We and other previously demonstrated that down-regulation of the anti-apoptotic protein survivin is an important determinant of the apoptotic response through which selinexor induces its anti-tumor activity in experimental models of different tumor types [13,14,15,16]. Here, BIRC5 is linked to neoplasm.